rs599839

[PMID 18262040] rs599839 and rs4970834 explain about 1% of the variation in circulating LDL-cholesterol levels. “When we look at this particular genetic variance, of all the cholesterol variation among the population, 1% of it can be attributed to this particular locus,” said Sandhu. “This is equivalent to more established genes for LDL regulation, particularly APOE.”

Another study also reports an association between rs599839(A) and higher LDL levels, in over 4,000 Caucasian Europeans. In one study, the (A) allele is associated with a 6% increase in nonfasting serum LDL, and in another, with a 25% increase in fasting serum LDL.[PMID 18179892]

rs646776 is a surrogate for rs599839, with linkage r²=0.88. [PMID 18979498] rs599839, rs4970834 and rs17228212 associated with non-HDL

[PMID 19380133] Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis

[PMID 19164808] Large scale association analysis of novel genetic loci for coronary artery disease

[PMID 19487539] Large scale replication analysis of loci associated with lipid concentrations in a Japanese population

[PMID 19837406] Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction The Ludwigshafen Risk and Cardiovascular Health Study

[PMID 19955471] Genetic Variants Identified in a European Genome-Wide Association Study That Were Found to Predict Incident Coronary Heart Disease in the Atherosclerosis Risk in Communities Study

[PMID 20370913] Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data

[PMID 20694560] Common genetic polymorphisms in Moyamoya and atherosclerotic disease in Europeans

[PMID 21463265] Association of SNP rs17465637 on Chromosome 1q41 and rs599839 on 1p13.3 with Myocardial Infarction in an American Caucasian Population

[PMID 22537824] Smoking interacts with HLA-DRB1 shared epitope in the development of ACPA-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA).

[PMID 18193044] Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

[PMID 18462017] Mapping the genetic architecture of gene expression in human liver.

[PMID 18649068] The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol.

[PMID 18852197] Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants.

[PMID 19065533] [Association of single nucleotide polymorphism rs599839 on chromosome 1p13.3 with premature coronary heart disease in a Chinese Han population].

[PMID 19161620] An open access database of genome-wide association results.

[PMID 19656773] A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.

[PMID 19660754] Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.

[PMID 19679263] Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study.

[PMID 19750184] Genome-wide association studies for atherosclerotic vascular disease and its risk factors.

[PMID 19802338] Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.

[PMID 19913121] Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.

[PMID 19924713] Use of longitudinal data in genetic studies in the genome-wide association studies era: summary of Group 14.

[PMID 19951432] Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.

[PMID 20017982] Genome-wide association analysis of cardiovascular-related quantitative traits in the Framingham Heart Study.

[PMID 20017983] Evaluation of population impact of candidate polymorphisms for coronary heart disease in the Framingham Heart Study Offspring Cohort.

[PMID 20018038] Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study.

[PMID 20098575] Genetics and cardiovascular disease: Design and development of a DNA biobank.

[PMID 21804106] Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration.

[PMID 21984477] Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease.

[PMID 22380622] The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis.

[PMID 22962622] Early Vascular Alterations in SLE and RA Patients—A Step towards Understanding the Associated Cardiovascular Risk

[PMID 23364394] A genome-wide association study of a coronary artery disease risk variant

[PMID 23535823] A sequence variant associated with Sortilin-1 (SORT1) on 1p13.3 is independently associated with Abdominal Aortic Aneurysm

[PMID 24622110] Multi-Ancestral Analysis of Inflammation-Related Genetic Variants and C-Reactive Protein in the Population Architecture using Genomics and Epidemiology (PAGE) Study

[PMID 23404648] An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease.

[PMID 24251769] LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease

[PMID 26405538] Association of FURIN and ZPR1 polymorphisms with metabolic syndrome

[PMID 26464717] Association of variants in CELSR2-PSRC1-SORT1 with risk of serum lipid traits, coronary artery disease and ischemic stroke

rs599839 is linked to the PSRC1 and CELSR2 genes. It is strongly associated with heart disease risk.

rs599839 was associated with a variation in the Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity, which shows a strong association with atherosclerosis in humans [R].

rs599839 (no reported alleles) is significantly associated with the risk of developing coronary artery disease (CAD) [R, R1, R2, R3, R4].

rs599839 was significantly associated with incident coronary heart disease (CHD) [R, R, R2, R3]. 

rs599839 (no reported alleles) was significantly associated with C-reactive protein (P=2.0×10(-6)) levels [R].

rs599839 was significantly associated with metabolic syndrome (MetS) (P=0.0486) [R]. 

The minor allele ''G'' was associated with non-HDL cholesterol (high density lipoprotein-cholesterol) levels [R, R1, R2].

The minor allele ''G'' was associated with lower LDL-C (low density lipoprotein-cholesterol) levels  (p=9·0×10⁻⁸) [R].

The minor allele ''G'' was strongly associated with LDL cholesterol concentrations (p approximately 3.1×10(-11), 4.7 mg/dl decrease per minor G allele) in a Japanese population [R, R1, R2].

Compared to ''AA'' homozygotes, the levels of LDL-C, low density lipoprotein triglycerides (LDL-TRIG) and apolipoprotein B were decreased in carriers of at least one G-allele. The ''G'' allele was also associated with:

• an increasing radius of the LDL particles
• a significant decrease in the level of triglycerides (for the ''GG'' genotype)
• decreased levels of free fatty acids (FFA)
• decreased levels of free glycerol and free cholesterol

With each ''G'' allele the prevalence of CAD (coronary artery disease) decreased significantly (OR= 0.806; P=0.006) in the Ludwigshafen Risk and Cardiovascular Health Study [R, R1, R2, R3]. 

The ''G'' allele was strongly associated with Moyamoya disease (MMD) (is a chronic, occlusive cerebrovascular disease) (OR = 2.17; p = 0.01) [R].

Patients carrying the ''G'' allele exhibited more severe endothelial dysfunction (FMD%: 4.61 ± 3.94%) than those carrying the wild allele A (FMD%: 6.01 ± 5.15%) in patients with rheumatoid arthritis (RA) (P = 0.08) [R].

The ''G'' allele was significantly associated with Abdominal aortic aneurysm (AAA) (OR 0.81; P = 7.2 × 10(-14)) [R].